# ELUXADOLINE
> **ANDA213511** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2026-06-02
## Drug
- **FDA Application Number:** ANDA213511
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELUXADOLINE
- **Generic name:** Eluxadoline
- **Active ingredients:** ELUXADOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AUROBINDO PHARMA
- **First approval:** 2026-06-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213511)
---
*MORVS · CC0 1.0*